Long-term Use of Cholesterol-lowering Medications May Benefit Some Prostate Cancer Patients, Trial Shows

Long-term Use of Cholesterol-lowering Medications May Benefit Some Prostate Cancer Patients, Trial Shows
Long-term treatment with atorvastatin, a cholesterol-lowering medicine, may reduce the proliferation of prostate cancer cells in some patients, a randomized trial suggests. Results from the trial were published in the study, “Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy—A Randomized, Double-blind, Placebo-controlled Clinical Trial,” in the journal European Urology. Atorvastin is a type of statin, which is a medication that lowers cholesterol. The use of statins is associated with improved prostate cancer-specific survival, a
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *